Abstract:Learning from the antimalarial mechanism of artemisinin (ART) in nature, we explored methemoglobin (MHb) as a smart nanocarrier of ART, in which anticancer abilities can be turned on in situ through the upregulated reducing capacity of tumor tissue. Ultra violet–visible, electron paramagnetic resonance spectrometry and in vitro cell assessment proved that a reducing agent such as glutathione can work as an excellent biogenic trigger to reduce ferric iron in MHb to the ferrous state, activating the ability of ART to generate free radicals and resulting in cytotoxicity and apoptosis. In vivo investigations showed that the MHb–ART complex had encouraging anticancer outcomes. The bioinspired nanocarrier may pave a new way to achieve targeted toxicity to cancer cells with extremely low side effects. A hemoglobin complex that uses tumor tissue to switch on a free radical–generating drug has potent in vivo activity, reports a team in China. Extracted from a herbal medicine used since antiquity, artemisinin is an effective anti-malaria medicine that splits molecules apart into cell-damaging radicals in the presence of ferrous iron (Fe2+). Jian Ji and colleagues from Zhejiang University have now made artemisinin perform the same trick in live mice bearing skin cancer tumors. They encapsulated artemisinin inside fully oxidized hemoglobin proteins featuring ferric (Fe3+) ions. The team then targeted glutathione, a compound that grows to elevated levels in many tumors, as a trigger that could reduce Fe3+ to Fe2+ in the biocarrier and activate the drug. In animal studies, the new complex arrested tumor growth considerably compared to control groups. Learning from the antimalarial mechanism of artemisinin in nature, we explored the methemoglobin as a smart nanocarrier of artemisinin. While the methemoglobin reacts very slow with artemisinin, the upregulated reducing capacity of tumor tissue can work as an excellent biogenic trigger to reduce ferric iron in methemoglobin to ferrous state, hence turn on the free radical generation ability and cytotoxicity of artemisinin in situ. The bioinspired nanocarrier may pave a new way to achieve targeted toxicity to cancer cells with extremely low side effects.

Mn(ii) Mediated Degradation of Artemisinin Based on Fe3O4@MnSiO3-FA Nanospheres for Cancer Therapy in Vivo

Targeted Gsh-Exhausting And Hydroxyl Radical Self-Producing Manganese-Silica Nanomissiles For Mri Guided Ferroptotic Cancer Therapy

Multifunctional Mesoporous Nanoparticles As Ph-Responsive Fe2+ Reservoirs and Artemisinin Vehicles for Synergistic Inhibition of Tumor Growth

Construction of Arsenic-Metal Complexes Loaded Nanodrugs for Solid Tumor Therapy: A Mini Review.

Artesunate-loaded poly (lactic-co-glycolic acid)/polydopamine-manganese oxides nanoparticles as an oxidase mimic for tumor chemo-catalytic therapy

Methemoglobin As A Redox-Responsive Nanocarrier to Trigger the in Situ Anticancer Ability of Artemisinin

The Application of Fe3o4 Nanoparticles in Cancer Research: A New Strategy to Inhibit Drug Resistance

Enhanced Fe(II)-artemisinin-mediated chemodynamic therapy with efficient Fe(III)/Fe(II) conversion circulation for cancer treatment

Fe(II) and Tannic Acid-Cloaked MOF as Carrier of Artemisinin for Supply of Ferrous Ions to Enhance Treatment of Triple-Negative Breast Cancer

Reversal in Multidrug Resistance by Magnetic Nanoparticle of Fe3o4 Loaded with Adriamycin and Tetrandrine in K562/A02 Leukemic Cells

Dihydroartemisinin-loaded Magnetic Nanoparticles for Enhanced Chemodynamic Therapy

Dihydroartemisinin loaded layered double hydroxide nanocomposites for tumor specific photothermal-chemodynamic therapy

Liensinine Inhibits Mitophagy to Potentiate Mitochondria-Targeting Artemisinin-Loaded Polymer Nanostructures for Breast Cancer Therapy

Magnetically Guided Delivery of DHA and Fe Ions for Enhanced Cancer Therapy Based on Ph-Responsive Degradation of DHA-loaded Fe 3 O 4 @C@mil-100(Fe) Nanoparticles

Smart Nanoplatform with Programmed Release of Dihydroartemisinin and Fe 2+ Self-Supply for Synergistic Cancer Therapy

Tween 80 Micelles Loaded with Fe3O4 Nanoparticles and Artemisinin for Combined Oxygen-Independent Ferroptosis Therapy of Cancer

Core–Shell Metal-Organic Frameworks As Fe2+ Suppliers for Fe2+-Mediated Cancer Therapy under Multimodality Imaging

Localized Fe(II)-Induced Cytotoxic Reactive Oxygen Species Generating Nanosystem for Enhanced Anticancer Therapy

Iron Oxide Nanocarrier-Mediated Combination Therapy of Cisplatin and Artemisinin for Combating Drug Resistance Through Highly Increased Toxic Reactive Oxygen Species Generation.

A gold cluster fused manganese dioxide nanocube loaded with dihydroartemisinin for effective cancer treatment via amplified oxidative stress

Self-activated arsenic manganite nanohybrids for visible and synergistic thermo/immuno-arsenotherapy